Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey.

@article{Park2012LipidloweringTI,
  title={Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey.},
  author={Jeong Euy Park and Chern-en Chiang and Muhammad Munawar and Gia Khai Pham and Apichard Sukonthasarn and Anastacio R Aquino and Kah Lin Khoo and Hon Wah Raymond Chan},
  journal={European journal of preventive cardiology},
  year={2012},
  volume={19 4},
  pages={781-94}
}
BACKGROUND Treatment of hypercholesterolaemia in Asia is rarely evaluated on a large scale, and data on treatment outcome are scarce. The Pan-Asian CEPHEUS study aimed to assess low-density lipoprotein cholesterol (LDL-C) goal attainment among patients on lipid-lowering therapy. METHODS This survey was conducted in eight Asian countries. Hypercholesterolaemic patients aged ≥18 years who had been on lipid-lowering treatment for ≥3 months (stable medication for ≥6 weeks) were recruited, and… CONTINUE READING